BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6979572)

  • 21. [Lymphocytes not bearing the typical T- and B-cell markers: their characteristics and effector functions].
    Petrov RV; Khalatian NA; Man'ko VM; Leskov VP
    Usp Sovrem Biol; 1980; 90(2):193-210. PubMed ID: 6160687
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
    Timonen T; Ortaldo JR; Herberman RB
    J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine antibody-dependent cell-mediated cytotoxicity: failure to detect effector cells equivalent to human K cells.
    Tada M; Hinuma S; Abo T; Kumagai K
    J Immunol; 1980 Apr; 124(4):1929-36. PubMed ID: 7365244
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 25. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation.
    Nilsson N; Carlsten H
    Cell Immunol; 1994 Oct; 158(1):131-9. PubMed ID: 8087860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent cell-mediated cytotoxicity and natural killer-cell phenomenon.
    Djeu JY
    J Am Vet Med Assoc; 1982 Nov; 181(10):1043-8. PubMed ID: 6184352
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay.
    Bradley TP; Bonavida B
    J Immunol; 1982 Nov; 129(5):2260-5. PubMed ID: 7119446
    [No Abstract]   [Full Text] [Related]  

  • 31. Large granular lymphocytes or "pit cells" from rat liver: isolation, ultrastructural characterization and natural killer activity.
    Bouwens L; Remels L; Baekeland M; Van Bossuyt H; Wisse E
    Eur J Immunol; 1987 Jan; 17(1):37-42. PubMed ID: 3816934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes.
    Wright SC; Bonavida B
    J Immunol; 1981 Apr; 126(4):1516-21. PubMed ID: 7204975
    [No Abstract]   [Full Text] [Related]  

  • 33. [The influence of tumor growth on natural cytotoxicity and activity of some lysosomal enzymes of human effector cells and the C3HA mouse splenocytes].
    Pogodina ON; Bulychev AG
    Tsitologiia; 2004; 46(8):675-84. PubMed ID: 15598012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice.
    Hochman PS; Cudkowicz G
    J Immunol; 1979 Sep; 123(3):968-76. PubMed ID: 313958
    [No Abstract]   [Full Text] [Related]  

  • 35. Large agranular lymphocytes: early non-specific effector cells in allograft rejection in the mouse.
    Gregory CD; Atkinson ME
    Immunology; 1984 Oct; 53(2):257-65. PubMed ID: 6386672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK-2.1: an NK-associated antigen detected with NZB anti-BALB/c serum.
    Pollack SB; Emmons SL
    J Immunol; 1982 Nov; 129(5):2277-81. PubMed ID: 6749989
    [No Abstract]   [Full Text] [Related]  

  • 37. Percoll density gradient centrifugation. (An improved method for the enrichment of lymphocyte subsets mediating different activities).
    Fumarola D; Antonaci S; Jirillo E; Munno I; Lucivero G; Bonomo L
    Ric Clin Lab; 1982; 12(3):485-91. PubMed ID: 6291125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
    Kiyohara T; Tanino T; Egawa K
    Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine T cells that lyse antibody-sensitized target cells. I. Kinetics and dose-response studies of control and cortisone-resistant thymocytes.
    Lamon EW; Williams BR; Fuson EW; Whitten HD; Walia AS
    J Immunol; 1978 Jan; 120(1):244-8. PubMed ID: 304867
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter.
    Tam MR; Emmons SL; Pollack SB
    J Immunol; 1980 Feb; 124(2):650-5. PubMed ID: 6985934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.